Sestamibi versus thallium subtraction scintigraphy in parathyroid localization: A prospective comparative study in patients with predominantly mild primary hyperparathyroidism
- 1 June 1997
- Vol. 121 (6), 601-605
- https://doi.org/10.1016/s0039-6060(97)90046-5
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Technetium-99m sestamibi parathyroid localization is accurate enough for scan-directed unilateral neck explorationBritish Journal of Surgery, 1996
- Hyperparathyroidism in high-risk surgical patients: evaluation with double-phase technetium-99m sestamibi imaging.Radiology, 1995
- Analysis of savings in operative time for primary hyperparathyroidism using localization with technetium 99m sestamibi scanThe American Journal of Surgery, 1995
- localization Studies in Patients with HyperparathyroidismSurgical Clinics of North America, 1995
- Teohnetium Tc 99m Sestamibi Scan for Localizing Abnormal Parathyroid Glands After Previous Neck OperationsSouthern Medical Journal, 1995
- Localization of parathyroid enlargement: experience with technetium-99m methoxyisobutylisonitrile and thallium-201 scintigraphy, ultrasonography and computed tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1994
- Pre‐Operative localization and interventional treatment of parathyroid tumors: When and how?World Journal of Surgery, 1991
- 99Tcm sestamibi — a new agent for parathyroid imagingNuclear Medicine Communications, 1989
- Parathyroid ImagingAnnals of Internal Medicine, 1987
- Parathyroid adenomas evaluated by Tl-201/Tc-99m pertechnetate subtraction scintigraphy and high-resolution ultrasonography.Radiology, 1985